Literature DB >> 34508348

Reinfections Are More Frequent Than Currently Considered in Countries With High Incidence of Coronavirus Disease 2019 (COVID-19) Cases Due to Stringent Definitions.

Luis Pampa-Espinoza1, Javier Silva-Valencia1, Manuel Fernandez-Navarro1, Carlos Padilla-Rojas1, Lely Solari1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34508348      PMCID： PMC8499902          DOI： 10.1093/cid/ciab783

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection.

Authors:  Isin Yagmur Comba; Irene Riestra Guiance; Cristina Corsini Campioli; Douglas Challener; Priya Sampathkumar; Robert Orenstein; Joel Gordon; Wendelyn Bosch; John C O'Horo
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-05-30

2.  Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru.

Authors:  Luis Pampa-Espinoza; Carlos Padilla-Rojas; Javier Silva-Valencia; Victor Jimenez-Vasquez; Iris Silva; Orson Mestanza; Priscila Lope Pari; Omar Cáceres; Henry Bailón-Calderón; Luis Bárcena-Flores; Marco Galarza; María García Mendoza; Ronnie Gavilán; Nancy Rojas Serrano; Miryam Palomino Rodriguez; Maribel Huaringa; Pamela Rios Monteza; Luis Ordoñez; Manuel Fernandez-Navarro; Natalia Vargas-Herrera; Lely Solari
Journal:  Open Forum Infect Dis       Date:  2022-03-16       Impact factor: 4.423

3.  Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study.

Authors:  Mahdi Barzegar; Amirreza Manteghinejad; Sara Bagherieh; Setayesh Sindarreh; Omid Mirmosayyeb; Shaghayegh Haghjooy Javanmard; Vahid Shaygannejad; Maryam Nasirian
Journal:  BMC Neurol       Date:  2022-10-08       Impact factor: 2.903

4.  Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data.

Authors:  Javier Silva-Valencia; Percy Soto-Becerra; Stefan Escobar-Agreda; Manuel Fernandez-Navarro; Oliver A Elorreaga; Percy Mayta-Tristán; Edward Mezones-Holguin; Lely Solari
Journal:  Vaccine       Date:  2022-09-28       Impact factor: 4.169
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.